Combining Microdroplet Reactions with ExD Fragmentation for Fast Characterization of Proteins and Antibody Subunits

Importance of the Topic

Microdroplet-assisted mass spectrometry has emerged as a rapid approach to accelerate chemical reactions such as disulfide reduction and protein digestion in submillisecond timescales.
In the context of monoclonal antibodies (mAbs), this strategy addresses the need for efficient structural characterization to ensure safety and efficacy in biotherapeutic development.

Study Objectives and Overview

This work aims to integrate microdroplet reaction technology with electron-capture dissociation (ECD) using an ExD cell for middle-down analysis of mAbs and their subunits.
Experiments using NIST mAb standards evaluated reduction efficiency, sequence coverage, and preservation of post-translational modifications.

Methodology

NIST mAb was buffer-exchanged into ammonium bicarbonate and diluted to 1 mg/mL.
Dithiothreitol (DTT) and mAb solution were sequentially aspirated by an autosampler needle, mixed in microdroplets within the Agilent Jet Stream source, and subjected to rapid reduction.
MS1 scans assessed reaction efficiency; targeted MS2 isolated the light chain and half-Fc fragments for ECD fragmentation.
Data analysis employed ExD Viewer software to map c/z and b/y fragment ions and compute sequence coverage.

Used Instrumentation

• Agilent 6545XT AdvanceBio LC/Q-TOF
• Agilent 1290 Infinity II Bio LC
• Agilent Jet Stream ion source
• ExD cell integrated in Q-TOF

Main Results and Discussion

Microdroplet reduction achieved efficient cleavage of interchain disulfides, producing abundant light and heavy chains.
ECD of the isolated light chain yielded 57 % sequence coverage under restrictive scoring, with nearly complete mapping of the CDR-L3 region and preserved N- and C-termini.
Supplemental CID energy enhanced fragment ion yield.
Offline enzymatic digestion of the half-Fc glycoform G0F followed by ECD provided 33 % coverage; intact disulfide bonds limited fragmentation in protected regions.

Benefits and Practical Applications

• Drastic reduction of sample preparation time through on-source microdroplet reactions.
• Automated workflow combining reduction, fragmentation, and data acquisition.
• Improved characterization of critical antibody domains, including complementarity-determining regions.
• Minimized risk of artifacts from prolonged offline reactions.

Future Trends and Possibilities

Adapting microdroplet methods to on-source enzymatic digestions could deliver deeper proteoform coverage and enhanced PTM profiling.
Integration with high-throughput screening platforms may accelerate biopharmaceutical quality control.
Further optimization of ExD cell parameters and exploration of alternative fragmentation techniques could improve sequence coverage in disulfide-rich regions.

Conclusion

The combination of microdroplet-facilitated reduction with ExD-based ECD on the Agilent 6545XT platform establishes a rapid, automated middle-down workflow for antibody characterization.
This approach delivers substantial sequence coverage, preserves critical modifications, and reduces overall analysis time and handling steps.

References

• Agilent application note 5994-6752EN